Viewing nowLestab 10 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Ilhwa Co., Ltd.

MFDS item code 201001001 · Approved 2010.01.28 · Insurance code 640902230
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is primarily used when dietary therapy and exercise are insufficient to control primary hypercholesterolemia and mixed dyslipidemia patients. It is also utilized as an adjunct treatment for patients with homozygous familial hypercholesterolemia, helping to lower total cholesterol and LDL cholesterol levels, thereby slowing the progression of atherosclerosis. Additionally, it can be used as an adjunct therapy for pediatric and adolescent patients with familial hypercholesterolemia who have high LDL cholesterol levels and cannot be effectively controlled with diet alone. It is also used to treat primary dysbetalipoproteinemia and contributes to reducing the risk of stroke, myocardial infarction, and vascular revascularization procedures in middle-aged and older individuals with a high risk of cardiovascular disease. Overall, this medication is effectively used to control cholesterol levels and reduce the risk of cardiovascular disease.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and should continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, the treatment goal, and the patient's response; it may be increased to a maximum of 20 mg per day. 3. Older adults : No dosage adjustment is necessary. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race : Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5mg. Administration of the 40milligram dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5milligrams. Administration of the 40milligram dose of this medicine is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in the pediatric population.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy in children under 10 years of age have not been established.
This medication should not be administered to certain patients. First, individuals allergic to the ingredients of this medication or with unexplained liver dysfunction should not use it. Patients with myopathy or taking certain immunosuppressants, and those with severe renal impairment should also avoid this medication. Women who are pregnant or breastfeeding, as well as women of childbearing potential, must use appropriate contraception methods and carefully weigh the risks and benefits. This medication requires special caution for individuals prone to muscle disease. Patients with mild to moderate renal impairment, hypothyroidism, family history of muscle issues, those who consume alcohol excessively, and Asian patients may require dosage adjustment. Patients with specific genetic metabolic disorders, such as lactose intolerance, should not take this medication. Patients with a history of liver disease or those who consume excessive alcohol should undergo liver function tests before starting this medication and regularly monitor liver function during treatment. Symptoms such as muscle pain, weakness, or spasms should be reported to healthcare professionals immediately, and muscle enzyme tests should be conducted if necessary. This medication can rarely cause serious skin reactions or liver damage, so if symptoms like rash, itching, or jaundice appear, use should be discontinued immediately, and consultation with a doctor is required. There may be interactions with other medications, so it is crucial to inform healthcare professionals about any current medications being taken, especially with certain antivirals, immunosuppressants, and fibrate drugs, as the risk of muscle disease may increase. It is advised not to take this medication if pregnant or breastfeeding, and women planning to become pregnant should consult with healthcare professionals and use appropriate contraception. In case of overdose, there is no specific antidote, and treatment should be carried out based on symptoms while monitoring liver function and muscle enzyme levels. Caution is required while driving or operating machinery as this medication may cause dizziness. This medication may show higher plasma concentrations in Asian individuals, so this should be considered in dosing decisions, and pediatric or adolescent patients should be carefully monitored for growth and development.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), drug eruption resembling psoriasis, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, elevated ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, appetite loss, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the effectiveness and prevent degradation of the medication.
Pink round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Ilhwa Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.